vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and Paysign, Inc. (PAYS). Click either name above to swap in a different company.

Creative Media & Community Trust Corp is the larger business by last-quarter revenue ($28.5M vs $22.8M, roughly 1.3× Paysign, Inc.). Paysign, Inc. runs the higher net margin — 6.0% vs -125.8%, a 131.7% gap on every dollar of revenue. On growth, Paysign, Inc. posted the faster year-over-year revenue change (45.8% vs 3.6%). Over the past eight quarters, Paysign, Inc.'s revenue compounded faster (31.3% CAGR vs -8.5%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

Paysign, Inc. is a specialized payment solutions provider that designs and delivers customized prepaid card programs, end-to-end payment processing services, and digital disbursement tools. Its core served segments include healthcare, corporate incentives, and general consumer markets, with primary operations and client bases across North America.

CMCT vs PAYS — Head-to-Head

Bigger by revenue
CMCT
CMCT
1.3× larger
CMCT
$28.5M
$22.8M
PAYS
Growing faster (revenue YoY)
PAYS
PAYS
+42.2% gap
PAYS
45.8%
3.6%
CMCT
Higher net margin
PAYS
PAYS
131.7% more per $
PAYS
6.0%
-125.8%
CMCT
Faster 2-yr revenue CAGR
PAYS
PAYS
Annualised
PAYS
31.3%
-8.5%
CMCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMCT
CMCT
PAYS
PAYS
Revenue
$28.5M
$22.8M
Net Profit
$-11.4M
$1.4M
Gross Margin
57.7%
Operating Margin
-125.6%
8.1%
Net Margin
-125.8%
6.0%
Revenue YoY
3.6%
45.8%
Net Profit YoY
-11.4%
-0.7%
EPS (diluted)
$-3.89
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
PAYS
PAYS
Q4 25
$28.5M
$22.8M
Q3 25
$26.2M
$21.6M
Q2 25
$29.7M
$19.1M
Q1 25
$32.3M
$18.6M
Q4 24
$27.5M
$15.6M
Q3 24
$28.6M
$15.3M
Q2 24
$34.4M
$14.3M
Q1 24
$34.0M
$13.2M
Net Profit
CMCT
CMCT
PAYS
PAYS
Q4 25
$-11.4M
$1.4M
Q3 25
$-12.5M
$2.2M
Q2 25
$-9.0M
$1.4M
Q1 25
$-6.1M
$2.6M
Q4 24
$-10.3M
$1.4M
Q3 24
$-10.4M
$1.4M
Q2 24
$-796.0K
$697.1K
Q1 24
$-3.7M
$309.1K
Gross Margin
CMCT
CMCT
PAYS
PAYS
Q4 25
57.7%
Q3 25
56.3%
Q2 25
61.6%
Q1 25
62.9%
Q4 24
58.9%
Q3 24
55.5%
Q2 24
52.9%
Q1 24
52.6%
Operating Margin
CMCT
CMCT
PAYS
PAYS
Q4 25
-125.6%
8.1%
Q3 25
-47.7%
7.3%
Q2 25
-30.3%
7.5%
Q1 25
-19.0%
13.4%
Q4 24
-128.8%
3.0%
Q3 24
-36.9%
4.5%
Q2 24
-1.6%
0.9%
Q1 24
-10.7%
-2.0%
Net Margin
CMCT
CMCT
PAYS
PAYS
Q4 25
-125.8%
6.0%
Q3 25
-47.5%
10.3%
Q2 25
-30.3%
7.3%
Q1 25
-18.9%
13.9%
Q4 24
-129.8%
8.8%
Q3 24
-36.3%
9.4%
Q2 24
-2.3%
4.9%
Q1 24
-11.0%
2.3%
EPS (diluted)
CMCT
CMCT
PAYS
PAYS
Q4 25
$-3.89
$0.02
Q3 25
$-23.52
$0.04
Q2 25
$-18.94
$0.02
Q1 25
$-20.73
$0.05
Q4 24
$97.71
$0.02
Q3 24
$-305.04
$0.03
Q2 24
$-98.64
$0.01
Q1 24
$-125.46
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
PAYS
PAYS
Cash + ST InvestmentsLiquidity on hand
$15.4M
Total DebtLower is stronger
$509.8M
Stockholders' EquityBook value
$265.4M
$48.5M
Total Assets
$859.2M
$276.3M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
PAYS
PAYS
Q4 25
$15.4M
Q3 25
$17.3M
Q2 25
$27.8M
Q1 25
$19.8M
Q4 24
$20.3M
Q3 24
$18.5M
Q2 24
$29.3M
Q1 24
$21.3M
Total Debt
CMCT
CMCT
PAYS
PAYS
Q4 25
$509.8M
Q3 25
$527.8M
Q2 25
$535.6M
Q1 25
$512.7M
Q4 24
$505.7M
Q3 24
$478.3M
Q2 24
$485.1M
Q1 24
$472.8M
Stockholders' Equity
CMCT
CMCT
PAYS
PAYS
Q4 25
$265.4M
$48.5M
Q3 25
$281.9M
$45.8M
Q2 25
$287.1M
$42.2M
Q1 25
$293.0M
$39.3M
Q4 24
$304.5M
$30.4M
Q3 24
$321.0M
$28.5M
Q2 24
$351.1M
$26.9M
Q1 24
$369.9M
$25.5M
Total Assets
CMCT
CMCT
PAYS
PAYS
Q4 25
$859.2M
$276.3M
Q3 25
$871.8M
$209.5M
Q2 25
$885.0M
$193.9M
Q1 25
$882.3M
$205.1M
Q4 24
$889.6M
$179.0M
Q3 24
$868.0M
$167.0M
Q2 24
$891.2M
$182.3M
Q1 24
$887.5M
$173.0M
Debt / Equity
CMCT
CMCT
PAYS
PAYS
Q4 25
1.92×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
Q3 24
1.49×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
PAYS
PAYS
Operating Cash FlowLast quarter
$5.8M
$48.1M
Free Cash FlowOCF − Capex
$47.5M
FCF MarginFCF / Revenue
208.7%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
35.29×
TTM Free Cash FlowTrailing 4 quarters
$51.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
PAYS
PAYS
Q4 25
$5.8M
$48.1M
Q3 25
$3.7M
$6.8M
Q2 25
$-2.5M
$3.6M
Q1 25
$1.2M
$-6.0M
Q4 24
$17.0M
$14.3M
Q3 24
$10.3M
$-20.2M
Q2 24
$3.9M
$20.6M
Q1 24
$1.6M
$8.2M
Free Cash Flow
CMCT
CMCT
PAYS
PAYS
Q4 25
$47.5M
Q3 25
$6.3M
Q2 25
$3.6M
Q1 25
$-6.1M
Q4 24
$14.2M
Q3 24
$-20.3M
Q2 24
$20.4M
Q1 24
$8.2M
FCF Margin
CMCT
CMCT
PAYS
PAYS
Q4 25
208.7%
Q3 25
29.2%
Q2 25
18.6%
Q1 25
-32.9%
Q4 24
91.0%
Q3 24
-133.0%
Q2 24
142.4%
Q1 24
62.1%
Capex Intensity
CMCT
CMCT
PAYS
PAYS
Q4 25
2.6%
Q3 25
2.1%
Q2 25
0.5%
Q1 25
0.4%
Q4 24
0.7%
Q3 24
0.8%
Q2 24
1.0%
Q1 24
0.4%
Cash Conversion
CMCT
CMCT
PAYS
PAYS
Q4 25
35.29×
Q3 25
3.05×
Q2 25
2.62×
Q1 25
-2.33×
Q4 24
10.43×
Q3 24
-14.03×
Q2 24
29.48×
Q1 24
26.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMCT
CMCT

Segment breakdown not available.

PAYS
PAYS

Plasma Industry$12.6M55%
Pharma Industry$9.6M42%
Other$558.4K2%

Related Comparisons